Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000951879 | SCV001098328 | likely benign | Congenital myasthenic syndrome 8 | 2023-08-04 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004029830 | SCV004871670 | uncertain significance | Inborn genetic diseases | 2022-05-11 | criteria provided, single submitter | clinical testing | The c.2563G>A (p.V855M) alteration is located in exon 15 (coding exon 15) of the AGRN gene. This alteration results from a G to A substitution at nucleotide position 2563, causing the valine (V) at amino acid position 855 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Department of Neurology, |
RCV000951879 | SCV001916964 | pathogenic | Congenital myasthenic syndrome 8 | 2021-09-22 | no assertion criteria provided | clinical testing |